Trametinib for progressive pediatric low-grade gliomas

Overview of attention for article published in Journal of Neuro-Oncology, August 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

twitter: 19 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 76 Dimensions

Readers on

mendeley: 85 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Medicina Mi Pasion Y Vida - Medicina Interna Hcv, 18 Oct 2018

#OnlineFirst: The MEK Inhibitor, Trametinib, may offer a promising treatment strategy for pediatric patients with unresectable…